Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed#

…, N Kochar, JA Leithead, G Therapondos… - Hepatology, 2009 - journals.lww.com
Current therapy for preventing the first variceal bleed includes beta-blocker and variceal band
ligation (VBL). VBL has lower bleeding rates, with no differences in survival, whereas beta-…

Outcomes of early liver transplantation for patients with severe alcoholic hepatitis

…, A Gurakar, JP Rice, MR Lucey, GY Im, G Therapondos… - Gastroenterology, 2018 - Elsevier
George Therapondos: acquisition of data, analysis and interpretation of data, revision of
manuscript. Hyosun Han: acquisition of data, analysis and interpretation of data, revision of …

A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis

…, SK Satapathy, G Therapondos… - Journal of …, 2020 - journal-of-hepatology.eu
Background & Aims Non-alcoholic steatohepatitis (NASH) is characterized by hepatocyte
steatosis, ballooning, and lobular inflammation which may lead to fibrosis. Lipotoxicity …

[PDF][PDF] Cardiac morbidity and mortality related to orthotopic liver transplantation

G Therapondos, AD Flapan, JN Plevris… - Liver …, 2004 - Wiley Online Library
This article briefly discusses the cardiac status of liver transplant recipients and their preoperative
cardiac evaluation. It describes in detail perioperative and early and late postoperative …

[HTML][HTML] Screening for nonalcoholic fatty liver disease in persons with type 2 diabetes in the United States is cost-effective: a comprehensive cost-utility analysis

…, DT Dieterich, ME Rinella, G Therapondos… - …, 2020 - gastrojournal.org
Methods We developed a Markov model to compare the strategies of screening and treatment
versus no screening and treatment of nonalcoholic steatohepatitis (NASH) in hypothetical …

Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine

…, SA Noureldin, G Therapondos… - Applied Physiology …, 2013 - cdnsciencepub.com
Nonalcoholic fatty liver disease (NAFLD) is associated with altered hepatic lipid composition.
Animal studies suggest that the hepatic ratio of phosphatidylcholine (PC) to …

Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the sustained alcohol use post–liver transplant score

BP Lee, E Vittinghoff, C Hsu, H Han, G Therapondos… - Hepatology, 2019 - journals.lww.com
Early liver transplant (LT) for alcohol‐associated disease (ie, without a specific sobriety
period) is controversial but increasingly used. Using the multicenter American Consortium of …

Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis

JCQ Velez, G Therapondos, LA Juncos - Nature Reviews Nephrology, 2020 - nature.com
The occurrence of acute kidney injury (AKI) in patients with end-stage liver disease constitutes
one of the most challenging clinical scenarios in in-hospital and critical care medicine. …

A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls

…, BM Arendt, SA Noureldin, G Therapondos… - Journal of the Academy …, 2014 - Elsevier
Background Poor diet and a sedentary lifestyle can contribute to nonalcoholic fatty liver
disease (NAFLD). Objective Our aim was to compare diet and physical activity of patients with …

A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation

…, L Lilly, ID McGilvray, G Therapondos… - Liver …, 2009 - journals.lww.com
Many centers require a minimal graft to body weight ratio (GBWR)≥ 0.8 as an arbitrary
threshold to proceed with right-lobe living donor liver transplantation (RL-LDLT), and there is …